Breaking News

Tweet TWEET

IRSH: Senator Investor Group LP: Form 8.3 - Actavis, Inc

  IRSH: Senator Investor Group LP: Form 8.3 - Actavis, Inc

UK Regulatory Announcement

NEW YORK

                                                                      FORM 8.3

                             IRISH TAKEOVER PANEL

  DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
                           RULES, 2007 (AS AMENDED)

 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
                                     MORE

 1. KEY INFORMATION
 Name of person dealing (Note 1)                 Senator Investment Group LP
 Company dealt in                                Actavis, Inc.
 Class of relevant security to which the         US$0.033 Ordinary Shares
  dealings being disclosed relate (Note 2)
 Date of dealing                                 3 July 2013
  

  2. INTERESTS AND SHORT POSITIONS

  

  (a) Interests and short positions (following dealing) in the class of
  relevant security dealt in (Note 3)
                                                Long            Short
                                                Number (%)      Number (%)
 (1) Relevant securities                         1,725,000 1.3%  
 (2) Derivatives (other than options)                           
 (3) Options and agreements to purchase/sell                    
 Total                                           1,725,000 1.3%  
 (b) Interests and short positions in relevant securities of the company,
  other than the class dealt in (Note 3)
 Class of relevant security:                     Long            Short
                                                Number (%)      Number (%)
 (1) Relevant securities                                        
 (2) Derivatives (other than options)                           
 (3) Options and agreements to purchase/sell                    
 Total                                                          
 1 February 2009

  3. DEALINGS (Note 4)

 

  (a) Purchases and sales
 Purchase/sale      Number of relevant securities     Price per unit (Note 5)
 Purchase           25,000                            $122.37
  

  (b) Derivatives transactions (other than options transactions)
                 Nature of        Number of relevant          Price per unit
  Product        transaction      securities
 name, e.g.                                               
  CFD                            
                                                              (Note 5)
                 (Note 6)         (Note 7)
                                                       
  

  (c) Options transactions in respect of existing relevant securities

  

  (i) Writing, selling, purchasing or varying
  Product   Writing,      Number of               Type,
  name,     selling,      securities              e.g.                 Option money
 e.g.     purchasing,  to which    Exercise  American,  Expiry  paid/received
  call      varying       the option   price      European    date     per unit
  option    etc.          relates                 etc.                 (Note 5)
                          (Note 7)
                                                          
  

 

  (ii) Exercising
 Product name,      Number of securities              Exercise price per unit
  e.g. call option                                       (Note 5)
                                                    
  

 

  (d) Other dealings (including transactions in respect of new securities) (Note 4)
  Nature of                                              Price per unit
 transaction        Details                        
                                                         (if applicable) (Note 5)
  (Note 8)
                                                    
 1 February 2009

  4. OTHER INFORMATION

 

  Agreements, arrangements or understandings relating to options or
  derivatives
  Full details of any agreement, arrangement or understanding between the
  person disclosing and any other person relating to the voting rights of any
 relevant securities under any option referred to on this form or relating to
  the voting rights or future acquisition or disposal of any relevant
  securities to which any derivative referred to on this form is referenced.
  If none, this should be stated.
 
  

 

  Is a Supplemental Form 8 attached? (Note 9) NO
 Date of disclosure                                  3 July 2013
 Contact name                                        Evan Gartenlaub
 Telephone number                                    212 376 4300
 If a connected EFM, name of                         
  offeree/offeror with which connected
 If a connected EFM, state nature of                 
  connection (Note 10)
 1 February 2009

Contact:

Senator Investor Group LP
 
Press spacebar to pause and continue. Press esc to stop.